vialroom

#semaglutide 2025-04-11

Friday51 messages8 participantstimes are UTC
Highlights from this day
  • VialBot — Verification log updated: GGPeps — evidence added, status unchanged. 16:56
  • area_percent — im at 15 and stuck, did anyone break a plateau without going up 16:59
  • spreadsheet_stu — back after 17 months off, do i restart at 0.25 or somewhere higher 18:32
  • bea_reconstitutes — steady state is the bit people skip, judging a new dose after eight days tells you almost nothing 18:54
  • VialBot — Assay note: SSA lot H-2814 reported at 99.2% of label content. 19:51
CO

STEP is several trials, so saying STEP said x is usually wrong without a number after it

❤️1
TT

dose day is sunday for me only because thats when i remember, not because sunday matters

went too fast once

CO

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down

U1

is the plateau usually appetite coming back or just the scale stopping

U1

restarted after 7 months off at a low dose and the nausea arrived exactly like the first time
i stayed on 1.7 for 24 months and never went to 2.4, appetite was already where i needed it

TT

for the archive SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

my PeptideMeter report on the SGN vial came back 97.4 against a certificate saying 99

lost about 37kg on the low doses before i even got to 1, which surprised me

SS

i dont think the plateau is a dose problem most of the time, but i cant prove that

SS

changed my mind on the four week rule, i think it depends entirely on how the current dose feels
the appetite effect faded for me around 20 months and going up fixed it for a while

VB

Verification log updated: GGPeps — evidence added, status unchanged.

11🤝4

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution
compounded and brand felt the same to me at 1, which is one person and nothing more

AP

im at 15 and stuck, did anyone break a plateau without going up

Cited study
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
New England Journal of Medicine · 2021
68 weeks, semaglutide 2.4mg weekly against placebo, with lifestyle intervention in both arms.
📈1📉14❤️1
AP

while im here STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping

did anyone titrate slower than four weeks a step and how did that go

CP

the plateau hit me at 30 weeks and moved again about a month later without a dose change

CP

the long half life flattens the trough more than people expect, i never felt a day seven dip, we shall see

CO

FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure, happy to be corrected

SS

the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

back after 17 months off, do i restart at 0.25 or somewhere higher

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
VB

Testing queue: 9 submissions open, 116 awaiting dispatch.

CO

whats the actual licensed ceiling, i keep seeing different numbers

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
BR

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

13🙏16⚠️1
AP

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule, thats one data point

quick one brand vs compounded, is there a difference people can actually feel

i stayed on 1.7 for 9 months and never went to 2.4, appetite was already where i needed it

VB

Assay note: SSA lot H-2814 reported at 99.2% of label content.

💀17
AP

five week steps worked better for me than four, purely on how the second week felt

AP

how long till steady state, ive read the half life is about a week

VB

Archive lookup: area_percent first appears in this channel on 2024-09-08.